The latest CDC numbers show a 5.0% increase of measles cases from week-to-week. The US total reached 4,080 confirmed cases, 78% above all of 2025.
|Videos|May 1, 2020
Contagion Live News Network: Coronavirus Updates for May 1, 2020
Author(s)Contagion® Editorial Staff
A brief summary of our daily COVID-19 coverage.
Advertisement
Hello and thank you for joining Contagion. I’m assistant editor Grant Gallagher, here with an update on our COVID-19 coverage on May 1, 2020.
This morning, we covered a survey out of China which found children’s depression and anxiety increase substantially in COVID-19 isolation. Investigators of the survey will continue to follow the situation to evaluate any long term trauma or ramifications on childhood development.
We also covered a study which suggested that men are more like to face fatal cases of COVID-19 than women. In a study of 43 hospitalized patients in China, men had nearly 2.5 times the death rate of women.
The reasons for the correlation between male sex and more severe disease are not clear, and it is not certain if the disparity is innately biological or lifestyle related. However, authors of the study posited that one factor could be ACE2, the protein to which the COVID-19 and SARS viruses attach. It has been shown that circulating ACE2 levels are higher in men than in women and in patients with diabetes or cardiovascular diseases
For more on these stories and other infectious disease news, visit Contagionlive.com.
For Contagion, I’m Grant Gallagher, thanks for watching.
Advertisement
Related to this article
UTI guidelines are moving away from complicated or uncomplicated infections to localized or systemic classification terminologies. Guidelines author Zachary Nelson, PharmD, MPH, BCIDP, provides further insights on the changes including applying antibiograms, potential costs, and whether clinicians will embrace these new classifications.
With US measles cases nearing 3,900 this year and Pennsylvania reporting its fifth measles-related death, here is a review of how the virus spreads, how it is prevented and managed, and what severe disease looks like.
Vaxcyte's 31-valent pneumococcal conjugate vaccine candidate met every prespecified primary immunogenicity and safety endpoint against PCV20 and PCV21 in the OPUS-1 trial of 4,047 US adults.
Irkutsk anti-plague institute death prompts quarantines and conflicting official accounts.
A laboratory technician at a Siberian anti-plague institute has died of pneumonia of unknown cause, prompting quarantines and contact monitoring while Russian officials stop short of confirming plague.
A study finding clesrovimab comparable to palivizumab in protecting at-risk infants in their first RSV season was extended to demonstrate clesrovimab effective and well-tolerated when administered in their second season.
Lori Handy, MD, provides guidance in these areas, including presentation before rash onset, when patients should be considered for the inpatient setting, and what treatment looks like.